Robert J Ferrante, Isabelle Denghien, Sebastien Holbert, Jean Dausset, Tamara Kiechle, Christopher A Ross, Christian Neri, Cheryll Wellington, Michael R Hayden, Adam Rosenblatt, Russell L Margolis
[
International C. elegans Meeting,
2001]
Huntington's disease (HD) is a neurodegenerative disease caused by polyglutamine (polyQ) expansion in the protein huntingtin (htt). Pathogenesis in HD appears to involve the formation of ubiquitinated neuronal intranuclear inclusions containing N-terminal mutated htt, abnormal protein interactions, and the aggregate sequestration of a variety of proteins (noticeably transcription factors). To identify novel htt-interacting proteins in a simple model system, we used a yeast two-hybrid screen with a Caenorhabditis elegans activation domain library (R. Barstead, ORMF, Oklahoma City, OK). We found a predicted WW domain protein (ZK1127.9) that interacts with N-terminal fragments of htt in two-hybrid tests. A human homologue of ZK1127.9 is CA150, a transcriptional coactivator with a N-terminal insertion that contains an unperfect (Gln-Ala)38 tract encoded by a polymorphic repeat DNA. CA150 interacted in vitro with full length htt from lymphoblastoid cells. The immunohistochemical expression of CA150 was markedly increased in human HD brain tissue, in comparison to normal age-matched human brain tissue, and showed aggregate formation with colocalization to ubiquitin-positive aggregates. In 432 HD patients, the CA150 repeat length explains a small but statistically significant amount of the variability in HD onset age. Our data suggest that abnormal expression of CA150, as mediated by interaction with polyQ-expanded htt, may alter transcription, and have a role in HD pathogenesis. Our data illustrate the value of using C. elegans for the direct identifcation of novel biochemical and genetic modifiers of human neurodegenerative disease pathogenesis [Holbert et al. (2001) Proc. Natl. Acad. Sci. USA 98 1811-1816].